Cargando…

Horizons in cancer research. Volume 65 /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Watanabe, Hiroto S. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Science Publishers, Inc., 2017.
Colección:Horizons in cancer research ; vol. 65.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • HORIZONS IN CANCER RESEARCH VOLUME 65 ; HORIZONS IN CANCER RESEARCH VOLUME 65 ; CONTENTS ; PREFACE ; Chapter 1 HEALTH PROMOTING ACTIVITY OF MYRICETIN: A NATURAL FLAVONOID ; ABSTRACT; INTRODUCTION ; POTENTIAL HEALTH EFFECTS ; Antineoplastic Activity ; Mutagenic and Antimicrobial Activity ; Interactions with DNA/Antiatherosclerotic Activity ; Antiviral ; Antidiabetic ; Neuroprotectant ; Insilico Anticancer Activity of Myricetin ; ADME/T STUDIES ; CONCLUSION ; ACKNOWLEDGMENTS; REFERENCES ; Chapter 2 IS VASCULOGENIC MIMICRY A HALLMARK OF AN AGGRESSIVE TUMOR? ; ABSTRACT
  • ABBREVIATIONS INTRODUCTION; CLINICAL SIGNIFICANCE OF VASCULOGENIC MIMICRY ; VM BLOCKADE REDUCES TUMOR GROWTH RATE IN EXPERIMENTAL LUNG, BREAST, COLON, CERVICAL CANCER AND MELANOMA MOUSE MODELS ; VM INHIBITOR, LCS1269, RESTORES SENSITIVITY OF RESISTANT MELANOMA CELLS TO DNA-DAMAGING AGENTS; MELANOMA EDUCATES NON-CANCER CELLS TOWARDS VASCULOGENIC MIMICRY ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; Chapter 3 EDUCATED OPINION: BACTERIAL TOXINS AS A DIRECT CAUSE OF CANCER ; ABSTRACT; REFERENCES ; Chapter 4 IMMUNOLOGICAL ASPECTS OF STROMA IN OVARIAN CANCER ; ABSTRACT
  • Chapter 5 IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF SOLID TUMORS: A NEW KEY IN THE HANDS OF ONCOLOGISTS ABSTRACT ; INTRODUCTION ; THE BIOLOGY OF CTLA 4 ; THE BIOLOGY OF PD 1 PATHWAY ; DRUGS BLOCKING THE CTLA4 AND PD 1 PATHWAY ; MELANOMA ; Metastatic Setting ; Adjuvant Setting ; HEAD AND NECK CANCER ; BREAST CANCER ; UROLOGICAL CANCER ; LUNG CANCER ; Non-Small Cell Lung Cancer (NSCLC) ; Nivolumab ; Pembrolizumab ; Atezolizumab ; Durvalumab ; Avelumab; REFERENCES